Mark S. Andrew, MD

Dr. Andrew is the Founder and Chief Scientific Officer. He is the co-inventor of Targeted Cell Separation and Extraction Technology TC-SET™ Medality Medical’s HydraSolve® is the second clinical application of TC-SET™, the first being the AquaLase® Liquefaction Device, a small-incision cataract removal technology on Alcon’s premier cataract machine, the INFINITI® Vision System, used routinely in more than 50 countries. Dr. Andrew, a Fellow of the American Academy of Ophthalmology, is a board-certified ophthalmologist with more than 25 years of experience. He received his medical degree from Jefferson Medical College (Sidney Kimmel Medical College) in Philadelphia, PA, and served his residency at Hahnemann University Hospital in Philadelphia. His scientific background includes basic science research in biochemistry, endocrinology, and immunology, as well as research in fluid dynamics at the National Eye Institute of the National Institutes of Health (NIH), Drexel University School of Biomedical Engineering, Jefferson Medical College (Sidney Kimmel Medical College), Wills Eye Hospital and the Penn State Health Milton S. Hershey Medical Center. Dr. Andrew holds 10 issued US patents, and 27 issued foreign patents, with more pending. Dr. Andrew’s inventions have led to 6 FDA clearances, 25 peer-reviewed journal articles, and numerous surgical textbook citations.

Brian Murray

Mr. Murray established BV Murray & Co. Inc., a boutique investment bank in 1996 after 17 years at Bear Stearns in the corporate finance department where he was a Senior Managing Director. Prior to joining Bear Stearns in 1978, he was a partner at HC Wainwright & Co, an institutional Wall Street research firm. Over his career, Mr. Murray has obtained extensive worldwide experience in mergers and acquisitions, valuations and public and private debt and equity of offerings. Mr. Murray holds a B.S. degree in Economics from Villanova University, an MBA with honors (majoring in finance and international business) from the University of Chicago and is a Chartered Financial Analyst (“CFA”).